Dragan Y P, Peterson J, Pitot H C
McArdle Laboratory for Cancer Research, University of Wisconsin Medical School, Madison 53706.
Carcinogenesis. 1993 Jul;14(7):1313-9. doi: 10.1093/carcin/14.7.1313.
Hepatocarcinogenesis was examined in an initiation--promotion protocol with a single initiating dose of 7,12-dimethylbenz[a]anthracene (DMBA) followed by promotion with phenobarbital (PB) in the Nagase analbuminemic rat (NA), the Sprague-Dawley rat (SD) and their F1 crosses. All rats received a 70% partial hepatectomy, followed at 24 h by 30 mg DMBA/kg body wt or the solvent. After a 2 week recovery following surgery, half of the solvent control and initiated groups received either basal diet or promotion with 0.05% PB mixed into the basal NIH-07 diet. After 12 weeks of promotion, the rats were killed and the livers perfused and fixed in situ with paraformaldehyde. Liver slices were paraffin embedded and stained for the placental isozyme of glutathione S-transferase (PGST). The number of altered hepatic foci (AHF) expressing PGST per liver was determined by quantitative stereology and used as an endpoint for comparison of initiation in the rat strains. The NA rat had a lower response to this initiation-promotion protocol than did the SD rat. The F1 progeny of the male NA and female SD rats were more similar to the NA parent in their responsiveness to initiation, whereas the F1 progeny of the female NA and male SD were similar to the SD parent in this respect. Putative mutagenesis and carcinogenesis were examined in the F1 progeny of the female NA and male SD rat. In these rats, serial liver sections were stained either for albumin to detect putative mutations at that locus, or PGST to identify putatively initiated hepatocytes. In the NA/SD F1, the number of single hepatocytes with a putative mutation at the albumin locus was the same (3.7 x 10(5)/liver) as those expressing a common marker of preneoplasia (PGST). The number of AHF expressing PGST was approximately 5% that of the single cells exhibiting an altered expression of albumin or PGST, indicating a possible quantitative correlation between initiation and mutation in vivo when individual hepatocytes with altered gene expression were counted. These studies also suggest that only a subpopulation of the putatively initiated hepatocytes expands clonally in the presence of the promoting agent, PB. The progeny of the female NA rat crossed with the SD male rat appears to provide a useful model in which to compare mutation and carcinogenesis simultaneously in vivo.
在启动 - 促进方案中研究了肝癌发生情况,该方案采用单次启动剂量的7,12 - 二甲基苯并[a]蒽(DMBA),随后在长濑无白蛋白血症大鼠(NA)、斯普拉格 - 道利大鼠(SD)及其F1杂交后代中用苯巴比妥(PB)进行促进。所有大鼠均接受70%的部分肝切除术,术后24小时给予30毫克DMBA/千克体重或溶剂。术后恢复2周后,一半的溶剂对照组和启动组大鼠接受基础饮食或用混入基础NIH - 07饮食中的0.05% PB进行促进。促进12周后,处死大鼠,原位灌注肝脏并用多聚甲醛固定。肝脏切片进行石蜡包埋,并对谷胱甘肽S - 转移酶的胎盘同工酶(PGST)进行染色。通过定量体视学确定每只肝脏中表达PGST的改变肝灶(AHF)数量,并将其用作比较大鼠品系启动情况的终点指标。NA大鼠对该启动 - 促进方案的反应低于SD大鼠。雄性NA大鼠与雌性SD大鼠的F1后代在对启动的反应性方面更类似于NA亲本,而雌性NA大鼠与雄性SD大鼠的F1后代在这方面类似于SD亲本。对雌性NA大鼠与雄性SD大鼠的F1后代进行了推定诱变和致癌作用的研究。在这些大鼠中,连续肝脏切片分别用白蛋白染色以检测该位点的推定突变,或用PGST染色以鉴定推定启动的肝细胞。在NA/SD F1中,在白蛋白位点有推定突变的单个肝细胞数量(3.7×10⁵/肝脏)与表达癌前病变常见标志物(PGST)的细胞数量相同。表达PGST的AHF数量约为表现出白蛋白或PGST表达改变的单个细胞数量的5%,这表明当对基因表达改变的单个肝细胞进行计数时,体内启动与突变之间可能存在定量相关性。这些研究还表明,在促进剂PB存在的情况下,只有推定启动的肝细胞亚群进行克隆性扩增。雌性NA大鼠与SD雄性大鼠杂交的后代似乎提供了一个有用的模型,可在体内同时比较突变和致癌作用。